Enlight To Report First Quarter 2024 Financial Results On Wednesday, May 8, 2024


(MENAFN- GlobeNewsWire - Nasdaq) TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT, TASE: ENLT), a leading global renewable energy platform, today announced it will release its financial results for the first quarter ended March 31, 2024, before market open on Wednesday, May 8, 2024.

Conference Call Information

Enlight will host a conference call to review its financial results and business outlook on Wednesday, May 8, 2024. Management will deliver prepared remarks followed by a question-and-answer session. Participants can join by conference call or webcast:

Date: Wednesday, May 8, 2024
Time: 8:00 a.m. ET
United States/Canada Toll Free: 1- 800-715-9871
International Toll: +1-646-307-1963
Conference ID: 4954929

Please register and join by webcast:
Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company's investor relations website at .

About Enlight

Founded in 2008, Enlight develops, finances, constructs, owns, and operates utility-scale renewable energy projects. Enlight operates across the three largest renewable segments today: solar, wind and energy storage. A global platform, Enlight operates in the United States, Israel and 9 European countries. Enlight has been traded on the Tel Aviv Stock Exchange since 2010 (TASE: ENLT) and completed its US IPO (NASDAQ: ENLT) in 2023. Learn more at co.

Investor Contact

Yonah Weisz
Director IR
...

Erica Mannion or Mike Funari
Sapphire Investor Relations, LLC
+1 617 542 6180
...


MENAFN18042024004107003653ID1108112983


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.